About Sapala Organics
Sapala Organics is a company based in Hyderabad (India) founded in 2005 was acquired by Suven Pharmaceuticals in June 2024. Sapala Organics has raised $734.96 thousand across 1 funding round from investors including Ventureast, Suven Pharma and Apidc. The company has 198 employees as of March 27, 2024. Sapala Organics offers products and services including Nucleoside and Phosphoramidites Derivatives, Linkers and Spacers, PEG Derivatives, and Miscellaneous Products. Sapala Organics operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
- Headquarter Hyderabad, India
- Employees 198 as on 27 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Sapala Organics Private Limited
- Date of Incorporation 04 Aug, 2005
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$5.85 M (USD)33.65as on Mar 31, 2021
-
Net Profit
$587.97 K (USD)5.76as on Mar 31, 2021
-
EBITDA
$825.97 K (USD)0.21as on Mar 31, 2021
-
Total Equity Funding
$734.96 K (USD)
in 1 rounds
-
Latest Funding Round
$734.96 K (USD), Seed
Mar 10, 2007
-
Investors
Ventureast
& 2 more
-
Employee Count
198
as on Mar 27, 2024
-
Acquired by
Suven Pharmaceuticals
(Jun 13, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sapala Organics
Sapala Organics offers a comprehensive portfolio of products and services, including Nucleoside and Phosphoramidites Derivatives, Linkers and Spacers, PEG Derivatives, and Miscellaneous Products.
Specialized building blocks for oligonucleotide synthesis and drug development.
Compounds for drug delivery and molecular connections in therapies.
Used for enhancing solubility in nucleic acid-based treatments.
Various compounds supporting research in medicinal chemistry.
People of Sapala Organics
Unlock access to complete
Unlock access to complete
Funding Insights of Sapala Organics
Sapala Organics has successfully raised a total of $734.96K through 1 strategic funding round. The most recent funding activity was a Seed round of $734.96 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sapala Organics
Sapala Organics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Ventureast, Suven Pharma and Apidc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology, healthcare, and clean environment sectors since 1997.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Contract manufacturing and development of APIs and formulations are provided.
|
Locked | Locked | Locked |
Investor details for Sapala Organics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sapala Organics
Investment portfolio details for Sapala Organics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sapala Organics
Detailed financials for Sapala Organics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sapala Organics Comparisons
Peer comparison for Sapala Organics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sapala Organics
Sapala Organics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
|
| Locked | Locked | Locked |
Integrated drug discovery and preclinical development services are provided.
|
|
| Locked | Locked | Locked |
Fluorinated compounds are synthesized and manufactured customly for various industries.
|
|
| Locked | Locked | Locked |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
Detailed competitors of Sapala Organics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sapala Organics
Complete news archive for Sapala Organics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sapala Organics
Sapala Organics was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Sapala Organics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sapala Organics is a funded company, having raised a total of $734.96K across 1 funding round to date.
As of Mar 27, 2024, the latest employee count at Sapala Organics is 198.
Annual revenue of Sapala Organics is $5.85M as on Mar 31, 2021.
Sapala Organics was established in 2005 as a contract research organization focused on organic synthesis within life and material sciences sectors. Services encompass custom synthesis of diverse organic compounds, supported by analytical method development. The organization operates from Hyderabad, India, and is equipped with modern facilities for synthesis and analysis to meet research needs.
Sapala Organics's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Sapala Organics offers Nucleoside and Phosphoramidites Derivatives, Linkers and Spacers, PEG Derivatives, and Miscellaneous Products.
Sapala Organics has 3 investors. Key investors include Ventureast, Suven Pharma, and Apidc.
The valuation of Sapala Organics is $743.21K as of Mar 2007.